AGRITX, a pioneer in a new era of poultry wellness and sustainability, announced the formation of a Consortium to evaluate methods for addressing transmission of harmful bacteria during the hatchery phase of production. AGRITX developed F-65, a patent-pending formula comprised of probiotics, prebiotics, amino acids, vitamins, and minerals. F-65 is applied to broiler chick eggs at the hatchery prior to set and is absorbed through the porous shell to establish resilient embryo microbiomes.
The early success of AGRITX F-65 demonstrates the efficacy of an eggshell application, and the goal of the Consortium is to evaluate similar hatchery-based interventions. “It’s surprising how little focus there is on intercepting pathogens at this stage of production,” said Sloan. “To better understand how to combat bacteria like Salmonella or Campylobacter at the hatchery, this group is developing models that mimic colonization and transmission within the typical environment.”
The Consortium is comprised of avian veterinarians, scientists, and researchers with unique specializations. They convene monthly to collaborate and share updates. AGRITX will post significant milestones and updates on the company’s blog page regularly throughout the remainder of the year.
ABOUT AGRITX:
AGRITX is an AgTech startup developing patented avian nutritional formulas to positively impact avian gut health from embryo to processing. AGRITX leadership envisions creating a sustainable future for poultry farmers by infusing resilience and forward-thinking into the industry while mitigating environmental impact. To learn more, visit www.agritx.farm
Related posts
